ロード中...
IMMU-17. TARGETING GLIOBLASTOMA WITH DNAM-1-BASED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
BACKGROUND: Genetically engineered T cells that express a chimeric antigen receptor (CAR) have shown powerful anti-tumor activity in extracranial malignancies. This concept is now also being explored against glioblastoma. However, many single target antigens used for CAR cell therapy are non-homogen...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847198/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.510 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|